AtriCure
ATRC
115 hedge funds and large institutions have $418M invested in AtriCure in 2014 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 7 closing their positions.
1,058% more call options, than puts
Call options by funds: $220K | Put options by funds: $19K
443% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 7
80% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 25
42% more capital invested
Capital invested by funds: $293M → $418M (+$124M)
34% more funds holding
Funds holding: 86 → 115 (+29)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$16.7M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$12.5M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$11.3M |
| 4 |
Millennium Management
New York
|
+$10.4M |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$9.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$8.96M |
| 2 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$8.59M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$4.78M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$4.02M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$2.98M |
ATRC Hedge Fund Activity: Q1 2014 in Review
115 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2014, worth a combined $418M — up 42% from $293M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ATRC positions and 7 closed out — a net gain of 31 holders — while 45 added to existing stakes and 25 trimmed.
The largest buyer was Polar Capital, opening a new position worth an estimated $16.7M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $8.96M.
- 115 institutional investors held AtriCure (ATRC) as of Q1 2014, up from 86 in Q4 2013.
- Funds reported $418M of AtriCure stock for Q1 2014, up 42% quarter-over-quarter.
- 38 funds opened new AtriCure positions in Q1 2014 and 7 closed out, a net change of +31 holders.
- The largest AtriCure buyer in Q1 2014 was Polar Capital, an estimated $16.7M added.
- The largest AtriCure seller in Q1 2014 was Manulife (Manufacturers Life Insurance), an estimated $8.96M sold.
Based on aggregated 13F filings for Q1 2014.